Google’s AI tool for diagnosing diabetic retinopathy is having trouble reading images while it's being tested in an Indian hospital, according to a report by The Wall Street Journal.

Tencent, a Chinese multinational investment holding conglomerate, and Merck KGaA, a German-based pharmaceutical, life sciences and technology company, are collaborating to increase disease awareness and provide more accessible healthcare services via digital platforms in China by leveraging AI and big data.

A Seattle-based startup, 98point6, is looking to become the Amazon of primary care, according to a profile by CNBC.

Five major pharmaceutical companies could each lose $500 million or more in revenue per year if a proposal from the Trump administration to reimburse Medicare Part B drugs based on an international pricing index (IPI) is finalized.

In order for AI technology to be safely incorporated into diagnostic and clinical decision support (CDS) software, stakeholders must first address its effectiveness and provide additional evidence for its usefulness in the clinical setting, according to Duke researchers.

Though AI continues to make great strides within radiology, some radiologists are still unprepared to educate medical students regarding its usage. This in turn may hinder medical students and trainees from pursuing radiology, according to a new editorial published in Academic Radiology.

Hospitals are now conducting wealth screenings with software that culls public data to see which patients are most likely to donate to the healthcare organization, The New York Times reported. The practice is increasingly common across hospitals, particularly large systems.

Deal volumes broke records in 2018 across the health services sector, and deal activity is likely to remain high in 2019 thanks to a number of positive market factors, according to PwC’s latest health services deals insights.

Media spotlighting of extraordinarily high hospital bills can pay off for patients on the hook for thousands of dollars after a hospital visit. Such is the case for one San Francisco resident who was stuck with a bill for more than $20,000—after her insurance paid its part—following a bicycle accident.

A new not-for-profit startup aimed at producing generic drugs will introduce 20 products in 2019, Reuters reported. The supplier, Civica Rx, initially expected to offer just 14 drugs in 2019, but will now likely exceed that after working with companies to produce additional medicines, company officials told Reuters.